Sight Sciences (SGHT)
(Delayed Data from NSDQ)
$6.76 USD
+0.44 (6.96%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $6.78 +0.02 (0.30%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SGHT 6.76 +0.44(6.96%)
Will SGHT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SGHT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SGHT
Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates
Integer (ITGR) Q2 Earnings Surpass Estimates
SGHT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates
Sight Sciences (SGHT) to Expand in Europe With New Launch
Other News for SGHT
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
Sight Sciences, Inc. (SGHT) Q2 2024 Earnings Call Transcript
Sight Sciences trading resumes
Sight Sciences trading halted, volatility trading pause
Morgan Stanley Sticks to Their Hold Rating for Sight Sciences (SGHT)